Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 0 | 0 | 1,210 | 680 | 1,390 |
| TOTAL | $0 | $0 | $1,210 | $680 | $1,390 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 1,980 | 2,510 | N/A |
| Other Non-Current Assets | 0 | 0 | 1,130 | 990 | 980 |
| TOTAL | $N/A | $N/A | $3,110 | $3,500 | $980 |
| Total Assets | $0 | $0 | $4,320 | $4,180 | $2,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 860 | 850 | 1,040 |
| Accrued Expenses | 0 | 0 | 2,340 | 3,170 | 3,970 |
| Other current liabilities | 0 | 0 | 6,580 | 6,850 | 6,730 |
| TOTAL | $0 | $0 | $9,780 | $10,870 | $11,740 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 1,200 | 1,310 | 1,340 |
| TOTAL | $N/A | $N/A | $2,470 | $2,590 | $3,140 |
| Total Liabilities | $0 | $0 | $12,250 | $13,460 | $14,880 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 10 | 10 | 10 |
| Other shareholders' equity | 0 | 0 | 140 | 130 | 140 |
| TOTAL | $0 | $0 | $77,170 | $77,120 | $77,100 |
| Total Liabilities And Equity | $0 | $0 | $89,420 | $90,580 | $91,980 |